Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors by Naume B, Gunderson K, Bruhn L, Sun H, Hicks J, Johansen FE, Aarøe J, Baumbusch LO, Kristensen VN, Liestøl K, Børresen-Dale A-L, Lingjærde OC

Get full text

Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors by Cheng, J, Demeulemeester, J, Wedge, DC, Vollan, HKM, Pitt, JJ, Russnes, HG, Pandey, BP, Nilsen, G, Nord, S, Bignell, GR, White, KP, Børresen-Dale, AL, Campbell, PJ, Kristensen, VN, Stratton, MR, Lingjærde, OC, Moreau, Y, Loo, PV

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations by Höglander, EK, Nord, S, Wedge, DC, Lingjærde, OC, Silwal-Pandit, L, Gythfeldt, HV, Vollan, HKM, Fleischer, T, Krohn, M, Schlitchting, E, Borgen, E, Garred, Ø, Holmen, MM, Wist, E, Naume, B, Van Loo, P, Børresen-Dale, A-L, Engebraaten, O, Kristensen, V